Boston-based Valo Health, which analyzes clinical data to identify molecules and predict their chances for use in drugs, raises $300M Series B

bostonbased valo health wichita businessjournal

Boston-based Valo Health, which analyzes clinical data to identify molecules and predict their chances for use in drugs, raises $300M Series B  —  A Boston-based company working to improve the way drugs are brought to the market has secured $110 million in Series B funding from Koch Disruptive Technologies.

Source

Keep visiting magazinecrunch.com for the latest news and updates.

Read Previous

Canalys: worldwide PC shipments grew 15% YoY in 2021 to 341M, the highest annual number since 2012; Apple shipped 28.3% more units, Acer 21.8%, and Dell 18% —

Read Next

Apple’s $19 Polishing Cloth has become its most back-ordered new product with shipments delayed until January; source: the company isn’t surprised by the demand

Leave a Reply